Where to meet the CMDC team, and the latest from our work with medical device companies and FDA.
Latest
CMDC is exhibiting at TCT 2026, the Transcatheter Cardiovascular Therapeutics conference, in San Diego. Stop by booth 4327 to meet our team and talk through your device program, from regulatory strategy and preclinical testing to clinical studies and quality systems.
Read more →CardioMed will be attending EuroPCR 2026 Conference in Paris, France, March 18th – 22nd. We’ve been invited to present topics for medical device innovation: Non-Clinical Testing of Structural Heart Devices to Support U.S. Market Approvals: Meeting Not-so-Obvious Regulatory Expectations. (Oral…
Read more →CardioMed Device Consultants are leading the Artificial Intelligence & Digital Health Session (March 9, 2026; 8:00 AM – 12:30 PM ET) at CRT 2026, bringing together leading clinicians, researchers, and innovators to explore the evolving role of artificial intelligence in…
Read more →After receiving Breakthrough Device Designation earlier in the year, a CardioMed client was accepted into the FDA program, TPLC Advisory Program Pilot (“TAP Pilot”). The purpose of TAP Pilot is to “spur more rapid development of high-quality, safe, effective, and…
Read more →Nothing here yet.
Tell us about your device and timeline.